Income Statement
CNS PHARMACEUTICALS, INC.
CNSP
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY |
|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - |
|
Operating Expenses
|
15.99 | 14.90 | 18.87 | 15.27 | 14.03 | 9.45 | 3.83 |
|
Research & Development
|
9.77 | 9.29 | 14.10 | 9.30 | 9.35 | 5.06 | 1.85 |
|
Selling, General & Administrative
|
6.21 | 5.61 | 4.77 | 5.97 | 4.68 | 4.39 | 1.98 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - |
|
Operating Income
|
-15.99 | -14.90 | -18.87 | -15.27 | -14.03 | -9.45 | -3.83 |
|
Non-Operating Income
|
0.14 | 0.04 | 0.01 | -0.01 | -0.01 | 0.00 | -0.04 |
|
Interest Income
|
- | - | 0.03 | - | - | - | - |
|
Interest Expense
|
- | - | 0.01 | 0.01 | 0.01 | 0.00 | 0.03 |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - |
|
Net Income
|
-15.85 | -14.86 | -18.85 | -15.27 | -14.04 | -9.46 | -3.88 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY |
|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - |
|
EBITDA
|
-15.99 | -14.90 | -18.87 | -15.27 | -14.03 | -9.45 | -3.83 |
|
Earnings Per Share (Basic)
|
-35.75 | -38.87 | -5.00 | -11.22 | - | - | - |
|
Diluted EPS
|
-35.75 | -38.87 | -5.00 | -11.22 | - | - | - |
|
Weighted Average Shares
|
0.44 | 0.38 | 3.77 | 1.36 | - | - | - |
|
Diluted Weighted Avg Shares
|
0.44 | 0.38 | 3.77 | 1.36 | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - |